Table 3.
Biomarker characteristics (blood sample type, detection method, biomarker type, number of modeling, and detection biomarkers) of 40 included studies on artificial intelligence–based ovarian cancer diagnosis with blood samples.
| Study | Blood sample type | Device or method | Biomarker type | Number of modeling biomarkers | Number of detection marker |
| Cai et al [24], 2024 | Blood | NRa | Protein, mixed | 52 | NR |
| Abuzinadah et al [28], 2023 | Blood | General chemical tests, blood routine tests | Mixed | 49 | 49 |
| Bifarin and Fernandez [29], 2024 | Serum | NR | Mixed | 17 | 17 |
| Cameron et al [30], 2023 | Serum | Spectrum | Mixed | 5 | 5 |
| Chen et al [31], 2023 | Plasma | LC-WGSb | DNA | NR | NR |
| Dhar et al [8], 2023 | Serum | LCMSc | Protein | 27 | 571 |
| Hamidi et al [32], 2023 | Serum | miRNA labeling kit and miRNA Oligo Chip | RNA | 10 | 2568 |
| Lai et al [33], 2023 | Serum | MSd | Protein | 7 | 95 |
| Li et al [34], 2024 | Plasma | Nanoflow cytometry, SECe, CA125 ELISAf kit, and HE4 ELISA kit | Protein | 7 | 7 |
| Reilly et al [35], 2023 | Serum | Roche cobas 6000 clinical analyzer | Protein | 7 | 7 |
| Zhang et al [36], 2023 | Blood | NR | Mixed | 25 | 25 |
| Ahamad et al [37], 2022 | Blood and serum | NR | Mixed | 47 | 47 |
| Bahado-Singh et al [38], 2022 | Plasma | Illumina Infnium MethylationEPIC BeadChip arrays or methylation analysis | DNA | 25 | 179,238 |
| Gupta et al [39], 2022 | Serum | UHPLC‑MSg | Mixed | 25 | 6336 |
| Hinestrosa et al [40], 2022 | Plasma | ACEh | Protein | 34 | 42 |
| Irajizad et al [25], 2022 | Plasma | LCMS analysis | Mixed | 7 | 475 |
| Kim et al [41], 2022 | Serum | Immunoassay, C8000 analyzer, diazo reagent | Mixed | NR | NR |
| Li et al [42], 2022 | Plasma | QIAamp Circulating Nucleic Acid kit | DNA | 5 | 1272 |
| Pais et al [43], 2022 | Serum | MALDINR-TOF MSi | Protein | CHCAj:26-57; SAk:12-113 | CHCA:8500; SA:8500 |
| Jeong et al [44], 2021 | Serum | 2-step chemiluminescent microparticle immunoassay | Protein | 16 | 3 |
| Lu et al [45], 2020 | Serum | Roche Cobas 8000 modular analyzer series | Protein | 2 | 2 |
| Banaei et al [46], 2019 | Serum | A microfluidic SERSl-based immunoassay method | Protein | 5 | 5 |
| Whitwell et al [47], 2018 | Serum | Olink’s multiplex immunoassay Oncology II panel | Protein | 92 | 92 |
| Ivanova et al [48], 2016 | Serum | MALDI-TOF MS | Protein | 7 | 200-400 |
| Jiang et al [49], 2013 | Serum | ELISA | Protein | 5 | 174 |
| Yang et al [50], 2013 | Serum | SELDI-TOF MSm | Protein | 184 | 184 |
| Shan et al [51], 2012 | Serum | Liquid chromatography electrospray tandem mass spectrometry | Mixed | 18 | 18 |
| Thakur et al [52], 2011 | Serum | SELDI-TOF MS | Protein | NR | NR |
| Donach et al [53], 2010 | Serum | Radioimmunoassay kits | Protein | 4 | 6 |
| Ziganshin et al [54], 2008 | Serum | MALDI-TOF MS or Ultraflex TOF mass spectrometer | Protein | MB-IMAC Cun:13; MB-WCX:11 | MB-HIC8o:135;MB-HIC18p:137; MB-IMAC Cu:115; MB-WCXq:96 |
| Liu et al [55], 2007 | Serum | prOTOF MS | Protein | NR | 96 |
| Zhang et al [56], 2007 | Serum | Radioimmunoassay kits | Protein | 4 | 4 |
| Chatterjee et al [57], 2006 | Serum | ELISA | Protein | 65 | 65 |
| Lin et al [58], 2006 | Plasma | SELDI analysis,WCX2 chip analysis,SAX2 chip analysis | Protein | 3 | 4 |
| Liu [59], 2006 | Serum | MS | Protein | NR | NR |
| Wu et al [60], 2006 | Plasma | SELDI-TOF MS | Protein | 5 | NR |
| Li and Ramamohanrao [61], 2004 | Serum | MS | Protein | 72 | 15,154 |
| Li et al [62], 2004 | Serum | SELDI-TOF MS | Protein | 10 | 15,155 |
| Zhang et al [63], 1999 | Serum | Radioimmunoassay kits, a spectrophotometric method with a kit | Mixed | 4 | 4 |
| Wilding et al [64], 1994 | Serum and plasma | Radioimmunoassay | Mixed | 8 | 8 |
aNR: not reported.
bLC-WGS: low-coverage whole genome sequencing.
cLC-MS: liquid chromatography-mass spectrometry.
dMS: mass spectrometry.
eSEC: size exclusion chromatography.
fELISA: enzyme-linked immunosorbent assay.
gUHPLC-MS: ultra-high performance liquid chromatography-mass spectrometry
hACE: alternating current electrokinetics.
iMALDINR-TOF MS: matrix-assisted laser desorption/Ionization neutral reflector time-of-flight mass spectrometry.
jCHCA: α-Cyano-4-hydroxycinnamic acid matrix.
kSA: sinapinic acid matrix.
lSERS: surface-enhanced Raman spectroscopy.
mSELDI -TOF MS: surface-enhanced laser desorption and ionization mass spectrometry.
nMB-IMAC Cu: magnetic beads MB-IMAC Cu.
oMB-HIC8: magnetic beads MB-HIC 8.
pMB-HIC18: magnetic beads MB-HIC 18.
qMB-WCX: magnetic beads MB-WCX.